Company Description
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.
It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization.
In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications.
The company sells its products through a network of independent sales agents and direct sales representatives.
Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
| Country | United States |
| Founded | 1990 |
| IPO Date | Jun 2, 2006 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 839 |
| CEO | Patrick S. Miles |
Contact Details
Address: 5818 El Camino Real Carlsbad, California 92008 United States | |
| Phone | 760-431-9286 |
| Website | atecspine.com |
Stock Details
| Ticker Symbol | ATEC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001350653 |
| CUSIP Number | 02081G201 |
| ISIN Number | US02081G2012 |
| Employer ID | 20-2463898 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Patrick S. Miles | Executive Chairman, Chief Executive Officer and President |
| J. Todd Koning | Executive Vice President and Chief Financial Officer |
| David P. Sponsel | Executive Vice President of Sales |
| Craig E. Hunsaker | Executive Vice President of People and Culture |
| Eric Dasso | Executive Vice President of Adjunctive Technologies |
| Scott Lish | Chief Operating Officer |
| Tyson Eliot Marshall | General Counsel and Corporate Secretary |
| Ali Shorooghi | Senior Vice President of Marketing |
| Jonathan Allen | Executive Vice President of Commercial Operations |
| Dr. Luiz Pimenta | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 17, 2024 | 8-K | Current Report |
| Jun 12, 2024 | 144 | Filing |
| May 21, 2024 | SD | Form - SD |
| May 7, 2024 | 10-Q | Quarterly Report |
| May 7, 2024 | 8-K | Current Report |
| Apr 26, 2024 | ARS | Filing |
| Apr 26, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 26, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 24, 2024 | 144 | Filing |
| Mar 22, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |